Annual Drug Patent Expirations for AVYCAZ
Avycaz is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has one hundred and eigthy-one patent family members in fifty-five countries.
The generic ingredient in AVYCAZ is avibactam sodium; ceftazidime. One supplier is listed for this compound. Additional details are available on the avibactam sodium; ceftazidime profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com